Free tool
FAERS Monitor: Nitro-Dur
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020145 or its brand name (Nitro-Dur, Nitroglycerin). Reports on generic versions are filed under their own applications.
Reports
41,486
Serious
33,732
81% of reports
Hospitalization
19,705
Death reported
5,555
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea3,552
- pain3,187
- fatigue2,860
- myocardial infarction2,772
- nausea2,731
- fall2,498
- chest pain2,475
- dizziness2,447
- drug ineffective2,420
- headache2,254
- diarrhoea2,182
- hypotension2,061
- asthenia1,965
- renal failure1,956
- death1,814
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 987 |
| 2005 | 1,123 |
| 2006 | 962 |
| 2007 | 719 |
| 2008 | 941 |
| 2009 | 1,246 |
| 2010 | 1,413 |
| 2011 | 2,285 |
| 2012 | 1,729 |
| 2013 | 882 |
| 2014 | 2,472 |
| 2015 | 1,485 |
| 2016 | 1,677 |
| 2017 | 1,755 |
| 2018 | 2,122 |
| 2019 | 2,302 |
| 2020 | 2,119 |
| 2021 | 2,233 |
| 2022 | 2,874 |
| 2023 | 2,854 |
| 2024 | 2,810 |
| 2025 | 2,707 |
| 2026 | 1,785 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,012,673 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myocardial infarctionSignal | 2,772 | 8.2 | 7.9 | 17,299 |
| renal failureSignal | 1,956 | 7.6 | 7.2 | 11,041 |
| chest painSignal | 2,475 | 6.9 | 6.6 | 12,310 |
| hypotensionSignal | 2,061 | 5.3 | 5.0 | 7,087 |
| fallSignal | 2,498 | 3.8 | 3.7 | 5,257 |
| dyspnoeaSignal | 3,552 | 3.2 | 3.1 | 5,467 |
| astheniaSignal | 1,965 | 2.7 | 2.5 | 2,057 |
| painSignal | 3,187 | 2.6 | 2.6 | 3,322 |
| dizzinessSignal | 2,447 | 2.5 | 2.4 | 2,232 |
| fatigue | 2,860 | 1.9 | 1.8 | 1,187 |
| headache | 2,254 | 1.8 | 1.8 | 864 |
| nausea | 2,731 | 1.8 | 1.7 | 912 |
| diarrhoea | 2,182 | 1.7 | 1.6 | 670 |
| death | 1,814 | 1.1 | 1.0 | 8 |
| drug ineffective | 2,420 | 0.9 | 0.9 | 13 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.